{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:04:19Z","timestamp":1780304659773,"version":"3.54.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC3403100"],"award-info":[{"award-number":["2023YFC3403100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BMU2022XY024"],"award-info":[{"award-number":["BMU2022XY024"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L252029"],"award-info":[{"award-number":["L252029"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L242056"],"award-info":[{"award-number":["L242056"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007928","name":"Ningbo Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","award":["2022Z142"],"award-info":[{"award-number":["2022Z142"]}],"id":[{"id":"10.13039\/501100007928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173726"],"award-info":[{"award-number":["82173726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574341"],"award-info":[{"award-number":["82574341"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioactmat.2026.02.018","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:07:14Z","timestamp":1771344434000},"page":"429-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Splenic dendritic cell-targeting mRNA transfection of H-type ionizable lipid-based LNPs for enhancing tumor immunotherapy"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6160-1684","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9648-7018","authenticated-orcid":false,"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6525","key":"10.1016\/j.bioactmat.2026.02.018_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1126\/science.aay3638","article-title":"A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis","volume":"371","author":"Krienke","year":"2021","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bioactmat.2026.02.018_bib2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra2206573","article-title":"Covid-19 vaccines - immunity, variants, boosters","volume":"387","author":"Barouch","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6656","key":"10.1016\/j.bioactmat.2026.02.018_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"issue":"6701","key":"10.1016\/j.bioactmat.2026.02.018_bib4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1126\/science.adk9428","article-title":"In vivo editing of lung stem cells for durable gene correction in mice","volume":"384","author":"Sun","year":"2024","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bioactmat.2026.02.018_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.02.018_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.02.018_bib7","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.bioactmat.2026.02.018_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.22203\/eCM.v047a11","article-title":"Development of an 'Off-the-Shelf' gene therapeutic nanoparticle formulation for incorporation into biomaterials for regenerative medicine applications","volume":"47","author":"O'Shea","year":"2024","journal-title":"Eur. Cell. Mater."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.02.018_bib9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4049\/jimmunol.0804324","article-title":"Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response","volume":"183","author":"Ruddle","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioactmat.2026.02.018_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2023.03.041","article-title":"Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses","volume":"357","author":"Pan","year":"2023","journal-title":"J. Contr. Release"},{"issue":"46","key":"10.1016\/j.bioactmat.2026.02.018_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303614","article-title":"Esterase-labile quaternium lipidoid enabling improved mRNA-LNP stability and spleen-selective mRNA transfection","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"34","key":"10.1016\/j.bioactmat.2026.02.018_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201910575","article-title":"Self-degradable lipid-like materials based on \"Hydrolysis accelerated by the intra-Particle Enrichment of Reactant (HyPER)\" for messenger RNA delivery","volume":"30","author":"Tanaka","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"26","key":"10.1016\/j.bioactmat.2026.02.018_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301606120","article-title":"Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination","volume":"120","author":"Ben-Akiva","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bioactmat.2026.02.018_bib14","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1039\/C8MD00249E","article-title":"Transfection by cationic gemini lipids and surfactants","volume":"9","author":"Damen","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioactmat.2026.02.018_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.omtn.2017.11.002","article-title":"Delivery pathway regulation of 3',3\u2033-Bis-Peptide-siRNA conjugate via nanocarrier architecture engineering","volume":"10","author":"Sun","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"19","key":"10.1016\/j.bioactmat.2026.02.018_bib16","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1039\/C3TB21506G","article-title":"Novel gemini cationic lipids with carbamate groups for gene delivery","volume":"2","author":"Zhao","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2026.02.018_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2016.05.051","article-title":"The role of disulfide-bridge on the activities of H-shape gemini-like cationic lipid based siRNA delivery","volume":"235","author":"Ma","year":"2016","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.bioactmat.2026.02.018_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.02.018_bib19","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","article-title":"Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation","volume":"37","author":"Miao","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.02.018_bib20","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"issue":"34","key":"10.1016\/j.bioactmat.2026.02.018_bib21","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.02.018_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0022-1759(91)90015-8","article-title":"In vivo anti-complementary activities of the cobra venom factors from naja naja and Naja haje","volume":"136","author":"Van den Berg","year":"1991","journal-title":"J. Immunol. Methods"},{"issue":"52","key":"10.1016\/j.bioactmat.2026.02.018_bib23","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioactmat.2026.02.018_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.02.018_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.02.018_bib26","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.bioactmat.2026.02.018_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206636","article-title":"Fast and dynamic mapping of the protein Corona on nanoparticle surfaces by photocatalytic proximity labeling","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.018_bib28","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41467-023-39768-9","article-title":"Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.018_bib29","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1038\/s41467-022-33044-y","article-title":"In situ analysis of nanoparticle soft corona and dynamic evolution","volume":"13","author":"Baimanov","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.018_bib30","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1038\/s41467-024-52104-z","article-title":"Tuning the fluidity and protein corona of ultrasound-responsive liposomal nanovaccines to program T cell immunity in mice","volume":"15","author":"He","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.02.018_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.018_bib32","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41467-020-16248-y","article-title":"Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver","volume":"11","author":"Miao","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.018_bib33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1994","article-title":"T-cell regulation: with complements from innate immunity","volume":"7","author":"Kemper","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.02.018_bib34","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2007-06-095018","article-title":"Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction","volume":"111","author":"Peng","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bioactmat.2026.02.018_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062869","article-title":"Complement-Opsonized nano-carriers are bound by dendritic cells (DC) via complement receptor (CR)3, and by B cell subpopulations via CR-1\/2, and affect the activation of DC and B-1 cells","volume":"22","author":"Bednarczyk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.018_bib36","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41467-024-47109-7","article-title":"Adhesion energy controls lipid binding-mediated endocytosis","volume":"15","author":"Groza","year":"2024","journal-title":"Nat. Commun."},{"issue":"6673","key":"10.1016\/j.bioactmat.2026.02.018_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bioactmat.2026.02.018_bib38","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1038\/cti.2016.19","article-title":"Local innate immune responses in the vaccine adjuvant-injected muscle","volume":"5","author":"Liang","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.bioactmat.2026.02.018_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","article-title":"From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases","volume":"131","author":"Pilkington","year":"2021","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.02.018_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.182.2.389","article-title":"Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products","volume":"182","author":"Sallusto","year":"1995","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.bioactmat.2026.02.018_bib41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2017.52","article-title":"A STING-activating nanovaccine for cancer immunotherapy","volume":"12","author":"Luo","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.02.018_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.02.018_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190333","article-title":"Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy","volume":"14","author":"Han","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.02.018_bib44","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41568-023-00615-0","article-title":"Stem-like exhausted and memory CD8(+) T cells in cancer","volume":"23","author":"Gebhardt","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.02.018_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/imr.13057","article-title":"Epigenetics and CD8(+) T cell memory","volume":"305","author":"Montacchiesi","year":"2022","journal-title":"Immunol. Rev."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:16:48Z","timestamp":1780301808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":45,"alternative-id":["S2452199X26000794"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.02.018","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenic dendritic cell-targeting mRNA transfection of H-type ionizable lipid-based LNPs for enhancing tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}